Aida Raigon-Ponferrada, María E.D. Recio*, Jose L. Guerrero-Orriach*, Alfredo Malo-Manso, Juan J. Escalona-Belmonte, Marta R. Aliaga, Alicia R. Fernández, Francisco J.F. García, Emilio A. Conejo and José Cruz-Mañas Pages 2998 - 3004 ( 7 )
Breast cancer is a complex heterogeneous disease that is categorized into several histological and genomic subtypes with relevant prognostic and therapeutical implications. Such diversity requires a multidisciplinary approach for a comprehensive treatment that will involve surgeons, radiotherapists and medical oncologists.
Breast cancer is classified as either local (or locoregional), which stands for 90-95% of cases, or metastatic, representing 5% of cases.
The management of breast cancer will be determined by the stage of the disease. The treatment of local breast cancer is based on surgery and/or radiotherapy. Systemic breast cancer requires chemotherapy and/or endocrine and/or biological therapy.
Anesthetic drugs and techniques, opioids, propofol, volatile agent, breast cancer, cancer recurrence, immune cells, natural killer cells.
Institute of Biomedical Research in Malaga [IBIMA], Malaga, Institute of Biomedical Research in Malaga [IBIMA], Malaga, Institute of Biomedical Research in Malaga [IBIMA], Malaga, Institute of Biomedical Research in Malaga [IBIMA], Malaga, Institute of Biomedical Research in Malaga [IBIMA], Malaga, Institute of Biomedical Research in Malaga [IBIMA], Malaga, Institute of Biomedical Research in Malaga [IBIMA], Malaga, Institute of Biomedical Research in Malaga [IBIMA], Malaga, Department of Oncology, Virgen de la Victoria University Hospital, Malaga, Institute of Biomedical Research in Malaga [IBIMA], Malaga